Innovative Ways to Democratize Precision Medicine Testing

• Learn how to optimize late-stage clinical development by designing and developing genomics solutions at scale
• Discover SOPHiA GENETICS’ market-leading lab network and regional strategic collaborations, particularly in the APAC region, democratizing genomics testing
• Gain insights into SOPHiA GENETICS’ regulatory and validation pathway for enabling broad and faster access to precision therapies.
• Explore how SOPHiA GENETICS’ unique hybrid deployment approach to liquid biopsy, combining centralized and decentralized testing, meets global regulatory requirements while paving the way for maximizing patient access to critical diagnostics

Speakers:

Jess Lambe

Vice President & Managing Director, BioPharma Business Development

SOPHIA GENETICS